| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
36,340,000 |
| Market
Cap: |
45.79(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.26 - $1.26 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Forte Biosciences is a biopharmaceutical company that had been advancing through clinical trials its product candidate, FB-401, which is a topical live biotherapeutic for the treatment of inflammatory skin diseases, including pediatric and adult patients with atopic dermatitis. Co. also has been developing its FB-102 program that addresses certain autoimmune diseases such as vitiligo and alopecia areata.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
118,865 |
118,865 |
218,865 |
| Total Buy Value |
$0 |
$75,040 |
$75,040 |
$179,712 |
| Total People Bought |
0 |
1 |
1 |
1 |
| Total Buy Transactions |
0 |
9 |
9 |
11 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Williams Donald Allen |
Director |
– • – |
2023-07-31 |
4 |
A |
$1.01 |
$59,999 |
D/D |
59,405 |
59,405 |
|
- |
|
| Riley Anthony A |
Chief Financial Officer |
• – – |
2023-07-31 |
4 |
A |
$1.01 |
$149,999 |
D/D |
148,514 |
176,776 |
|
- |
|
| Kornfeld Steven |
Director |
– • – |
2023-07-31 |
4 |
A |
$1.01 |
$99,999 |
D/D |
99,009 |
99,009 |
|
- |
|
| Chen Hubert C |
See remarks |
• – – |
2023-07-31 |
4 |
A |
$1.01 |
$75,000 |
D/D |
74,257 |
84,071 |
|
- |
|
| Wagner Paul A. |
See Remarks |
• • – |
2023-07-31 |
4 |
A |
$1.01 |
$249,999 |
D/D |
247,524 |
1,675,574 |
|
- |
|
| Gryska David W |
Director |
– • – |
2023-07-31 |
4 |
A |
$1.01 |
$149,999 |
D/D |
148,514 |
148,514 |
|
- |
|
| Wagner Paul A. |
See Remarks |
• • – |
2023-07-01 |
4 |
D |
$1.04 |
$2,551 |
D/D |
(2,453) |
1,428,050 |
|
- |
|
| Wagner Paul A. |
See Remarks |
• • – |
2023-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,250 |
1,430,503 |
|
- |
|
| Chen Hubert C |
See remarks |
• – – |
2023-07-01 |
4 |
D |
$1.04 |
$2,697 |
D/D |
(2,593) |
9,814 |
|
- |
|
| Chen Hubert C |
See remarks |
• – – |
2023-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
12,407 |
|
- |
|
| Riley Anthony A |
Chief Financial Officer |
• – – |
2023-07-01 |
4 |
D |
$1.04 |
$3,371 |
D/D |
(3,241) |
24,762 |
|
- |
|
| Riley Anthony A |
Chief Financial Officer |
• – – |
2023-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,375 |
28,003 |
|
- |
|
| Wagner Paul A. |
See Remarks |
• • – |
2022-12-16 |
4 |
B |
$1.07 |
$47,000 |
D/D |
44,024 |
1,379,049 |
2.81 |
- |
|
| Wagner Paul A. |
See Remarks |
• • – |
2022-12-15 |
4 |
B |
$1.03 |
$57,672 |
D/D |
55,976 |
1,335,025 |
2.81 |
- |
|
| Wagner Paul A. |
See Remarks |
• • – |
2021-09-07 |
4 |
S |
$4.35 |
$4,347,100 |
D/D |
(1,000,000) |
1,279,049 |
|
100% |
|
| Riley Anthony A |
Chief Financial Officer |
• – – |
2021-09-07 |
4 |
S |
$4.24 |
$106,105 |
D/D |
(25,000) |
11,065 |
|
100% |
|
| Darcy Thomas E |
Director |
– • – |
2021-01-13 |
4 |
OE |
$9.59 |
$4,793 |
D/D |
500 |
2,358 |
|
- |
|
| Riley Anthony A |
Chief Financial Officer |
• – – |
2020-06-29 |
4 |
B |
$14.11 |
$28,220 |
D/D |
2,000 |
36,065 |
2.74 |
- |
|
| Riley Anthony A |
Chief Financial Officer |
• – – |
2020-06-26 |
4 |
B |
$14.52 |
$68,225 |
D/D |
4,700 |
34,065 |
2.74 |
- |
|
| Wagner Paul A. |
See Remarks |
• • • |
2020-06-25 |
4 |
B |
$14.48 |
$101,356 |
D/D |
7,000 |
2,279,049 |
3.23 |
- |
|
| Riley Anthony A |
Chief Financial OfficerOfficer |
• – – |
2020-06-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
29,365 |
|
- |
|
| Darcy Thomas E |
Director |
– • – |
2020-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,858 |
1,858 |
|
- |
|
| Oliveira Steven Michael |
10% Owner |
– – • |
2020-04-14 |
4 |
B |
$1.19 |
$88,418 |
I/I |
74,301 |
2,873,450 |
1.5 |
15% |
|
| Oliveira Steven Michael |
10% Owner |
– – • |
2020-03-02 |
4 |
B |
$1.35 |
$87,756 |
I/I |
65,149 |
2,799,149 |
1.5 |
-34% |
|
| Gruber Harry E |
President, Science&Innovation |
• • – |
2020-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
13,941 |
23,685 |
|
- |
|
76 Records found
|
|
Page 2 of 4 |
|
|
